|
1.
|
Hassa PO, Haenni SS, Elser M and Hottiger
MO: Nuclear ADP-ribosylation reactions in mammalian cells: where
are we today and where are we going? Microbiol Mol Biol Rev.
70:789–829. 2006. View Article : Google Scholar
|
|
2.
|
Moss J, Balducci E, Cavanaugh E, et al:
Characterization of NAD: arginine ADP-ribosyltransferases. Mol Cell
Biochem. 193:109–113. 1999. View Article : Google Scholar
|
|
3.
|
Zolkiewska A, Nightingale MS and Moss J:
Molecular characterization of NAD: arginine ADP-ribosyltransferase
from rabbit skeletal muscle. Proc Natl Acad Sci USA.
89:11352–11356. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Corda D and Di Girolamo M: Functional
aspects of protein mono-ADP-ribosylation. EMBO J. 22:1953–1958.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Corda D and Di Girolamo M:
Mono-ADP-ribosylation: a tool for modulating immune response and
cell signaling. Sci STKE 2002. pe532002.PubMed/NCBI
|
|
6.
|
Helleday T, Bryant HE and Schultz N:
Poly(ADP-ribose) polymerase (PARP-1) in homologous recombination
and as a target for cancer therapy. Cell Cycle. 4:1176–1178. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Hao LX, Wang YL and LI YY: Correlation of
PARP expression with P-selectin and ICAM-1 expression in colorectal
carcinoma. Basic Clin Med. 26:882–887. 2006.
|
|
8.
|
Li M, Cai L and Wang Y: Effect of
poly(ADP-ribose) polymerase inhibition on liver metastasis of mouse
colorectal carcinoma CR26 cell line in vivo. Acta Acad Med Mil
Tert. 30:237–240. 2008.
|
|
9.
|
Wang YL and Hao LX: Effect of
5-aminoisoquinolinone on the adhesion of colon carcinoma. Chin J
Cancer Res. 19:119–123. 2007. View Article : Google Scholar
|
|
10.
|
Effect of poly(ADP-ribose) polymerase
inhibition on liver metastasis of mouse colorectal carcinoma CT26
cell line in vivo. Acta Acad Med Mil Tert. 29:1621–1624. 2008.
|
|
11.
|
Wang J, Nemoto E, Kots AY, Kaslow HR and
Dennert G: Regulation of cytotoxic T cells by ecto-nicotinamide
adenine dinucleotide (NAD) correlates with cell surface
GPI-anchored/arginine ADP-ribosyltransferase. J Immunol.
153:4048–4058. 1994.PubMed/NCBI
|
|
12.
|
Wang J, Nemoto E and Dennert G: Regulation
of CTL by ecto-nictinamide adenine dinucleotide (NAD) involves
ADP-ribosylation of a p56lck-associated protein. J Immunol.
156:2819–2827. 1996.PubMed/NCBI
|
|
13.
|
Okamoto S, Azhipa O, Yu Y, Russo E and
Dennert G: Expression of ADP-ribosyltransferase on normal T
lymphocytes and effects of nicotinamide adenine dinucleotide on
their function. J Immunol. 160:4190–4198. 1998.PubMed/NCBI
|
|
14.
|
Adriouch S, Ohlrogge W, Haag F, Koch-Nolte
F and Seman M: Rapid induction of naive T cell apoptosis by
ecto-nicotinamide adenine dinucleotide: requirement for
mono(ADP-ribosyl) transferase 2 and a downstream effector. J
Immunol. 167:196–203. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Akai T, Nabeya Y, Yahiro K, et al:
Helicobacter pylori induces mono-(adenosine
5′-diphosphate)-ribosylation in human gastric adenocarcinoma. Int J
Oncol. 29:965–972. 2006.
|
|
16.
|
Yang L, Wang Y, Sheng Y, Xiong W, Xu J,
Tang Y and Li X: The correlation of ART1 expression with
angiogenesis in colorectal carcinoma and it relationship with VEGF
and integrin αVβ3 expressions. Basic Clin Med. 9:1064–1069.
2012.
|
|
17.
|
Thyberg J, Hultgårdh-Nilsson A and Kallin
B: Inhibitors of ADP-ribosylation suppress phenotypic modulation
and proliferation of smooth muscle cells cultured from rat aorta.
Differentiation. 59:243–252. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Brac T and Ebisuzaki K: PolyADP
ribosylation and Friend erythroleukemic-cell differentiation:
action of poly(ADP-ribose) polymerase inhibitors. Differentiation.
34:139–143. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Colon-Otero G, Sando JJ, Sims JL, McGrath
E, Jensen DE and Quesenberry PJ: Inhibition of hemopoietic growth
factor-induced proliferation by adenosine diphosphate-ribosylation
inhibitors. Blood. 70:686–693. 1987.
|
|
20.
|
Francis G, Gray D, Berney J, Wing M,
Guimaraes J and Hoffbrand A: Role of ADP-ribosyltransferase in
differentiation of human granulocyte-macrophage progenitors to the
macrophage lineage. Blood. 62:1055–1062. 1983.PubMed/NCBI
|
|
21.
|
Kuo ML, Chau YP, Wang JH and Shiah SG:
Inhibitors of poly(ADP-ribose) polymerase block nitric
oxide-induced apoptosis but not differentiation in human leukemia
HL-60 cells. Biochem Biophys Res Commun. 219:502–508. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Terada M, Fujiki H, Marks PA and Sugimura
T: Induction of erythroid differentiation of murine erythroleukemia
cells by nicotinamide and related compounds. Proc Natl Acad Sci
USA. 76:6411–6414. 1979. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Luo J, Kamata H and Karin M: IKK/NF-kappaB
signaling: balancing life and death - a new approach to cancer
therapy. J Clin Invest. 115:2625–2632. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Karin M and Ben-Neriah Y: Phosphorylation
meets ubiquitination: the control of NF-κB activity. Annu Rev
Immunol. 18:621–663. 2000.PubMed/NCBI
|
|
25.
|
Virág L and Szabó C: The therapeutic
potential of poly(ADP-ribose) polymerase inhibitors. Pharmacol Rev.
54:375–429. 2002.
|
|
26.
|
Pan J, Fauzee NJ, Wang YL, et al: Effect
of silencing PARG in human colon carcinoma LoVo cells on the
ability of HUVEC migration and proliferation. Cancer Gene Ther.
19:715–722. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Loesberg C, van Rooij H and Smets LA:
Meta-iodobenzylguanidine (MIBG), a novel high-affinity substrate
for cholera toxin that interferes with cellular
mono(ADP-ribosylation). Biochim Biophys Acta. 1037:92–99. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Mota-Filipe H, Sepodes B, McDonald M,
Cuzzocrea S, Pinto R and Thiemermann C: The novel PARP inhibitor
5-aminoisoquinolinone reduces the liver injury caused by ischemia
and reperfusion in the rat. Med Sci Monit. 8:BR444–BR453.
2002.PubMed/NCBI
|
|
29.
|
Fromowitz FB, Viola MV, Chao S, et al: Ras
p21 expression in the progression of breast cancer. Hum Pathol.
18:1268–1275. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Qin JM, Fu XY, Li SJ, et al: Gene and
protein expressions of p28GANK in rat with liver regeneration.
World J Gastroenterol. 9:2523–2527. 2003.PubMed/NCBI
|
|
31.
|
Kato J, Zhu J, Liu C, et al:
ADP-ribosylarginine hydrolase regulates cell proliferation and
tumorigenesis. Cancer Res. 71:5327–5335. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Moss J, Stanley S, Nightingale M, et al:
Molecular and immunological characterization of ADP-ribosylarginine
hydrolases. J Biol Chem. 267:10481–10488. 1992.PubMed/NCBI
|
|
33.
|
Yau L, Litchie B, Thomas S, Storie B,
Yurkova N and Zahradka P: Endogenous mono-ADP-ribosylation mediates
smooth muscle cell proliferation and migration via protein kinase
N-dependent induction of c-fos expression. Eur J Biochem.
270:101–110. 2003. View Article : Google Scholar
|
|
34.
|
Bourne HR, Sanders DA and McCormick F: The
GTPase superfamily: conserved structure and molecular mechanism.
Nature. 349:117–127. 1991. View
Article : Google Scholar : PubMed/NCBI
|
|
35.
|
Hwang YS, Hodge JC, Sivapurapu N and
Lindholm PF: Lysophosphatidic acid stimulates PC-3 prostate cancer
cell matrigel invasion through activation of RhoA and NF-κB
activity. Mol Carcinog. 45:518–529. 2006.PubMed/NCBI
|
|
36.
|
Cho SG, Li D, Stafford LJ, et al: KiSS1
suppresses TNFα-induced breast cancer cell invasion via an
inhibition of RhoA-mediated NF-κB activation. J Cell Biochem.
107:1139–1149. 2009.
|
|
37.
|
Su X, Tang Z, Li Q, et al: Expression and
significance of RhoA and NF-κB in human gastric carcinoma. Zhonghua
Zhong Liu Za Zhi. 33:276–279. 2011.(In Chinese).
|
|
38.
|
Perona R, Montaner S, Saniger L,
Sanchez-Perez I, Bravo R and Lacal JC: Activation of the nuclear
factor-kappaB by Rho, CDC42, and Rac-1 proteins. Genes Dev.
11:463–475. 1997. View Article : Google Scholar : PubMed/NCBI
|
